Pew Funds Six Teams to Research Leading Questions in Biology and Disease

PHILADELPHIA—The Pew Charitable Trusts announced today the six pairs of researchers who will probe leading questions in biology and disease as Pew’s 2022 class of Innovation Fund investigators.

The scientists—alums of Pew’s biomedical programs in the United States and Latin America—will look to advance scientific discovery and improve human health by drawing on their expertise in subjects ranging from molecular biology and neuroscience to genetics and biochemistry.

“Collaboration and creativity drive all scientific innovation,” said Molly Irwin, vice president for research and science at Pew. “Together, these investigators are working to understand some of health and medicine’s biggest mysteries, and Pew is proud to support them.” 

For more than 35 years, Pew has encouraged collaboration among its diverse community of biomedical scientists, leading to the 2017 launch of the Innovation Fund. The fund, which is supported by the Kathryn W. Davis Peace by Pieces Fund, aims to promote creative and cross-disciplinary partnerships among alums of Pew’s biomedical scholar and Latin American fellow programs, with all holding assistant professor positions or higher eligible to apply.

This year’s Innovation Fund teams and research projects are:

Stukenberg and Zong will develop a new mouse model that better represents the way human cancers develop.

Woodson and Kaiser will study how repeat RNAs and their complexes with proteins cause neurotoxicity and neurodegeneration.

Mendoza-Cózatl and Nobile will study how plants and microbes interact in the context of iron uptake and utilization.

Castro-Obregón and Velasco will explore the protective mechanisms against aging in naked mole rats and Mexican axolotls.

Rohatgi and Lee will investigate the regulation of the APC protein and its interacting proteins in colorectal cancer.

Shapiro and Halassa will explore the connection between two areas of the brain—the prefrontal cortex and the mediodorsal thalamus—in modulating decision-making in patients with schizophrenia.

The Pew Charitable Trusts is driven by the power of knowledge to solve today’s most challenging problems.

National Homeownership Month

Article

37 Researchers Working to Transform Biomedical Science

Quick View
Article

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.

Pew-Supported Scientists Partner on New Biomedical Research Projects
2022 Innovation Fund
Article

Scientists Partner on New Biomedical Research Projects

Quick View
Article

Collaboration is often at the forefront of scientific discovery and biomedical research has long benefited from this approach.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.